Clinical trial
Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With…
NCT00195546 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195546 |
|---|---|
| Title | Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study of DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause |
| Intervention type | Drug |
| Interventions | DVS-233 |
| Enrollment | 465 |
| Start date | Apr 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jun 1, 2007 |
| Countries | Belgium, Croatia, Czechia, Finland, France, Hungary, Mexico, Netherlands, Poland, Romania, South Africa, Spain and 3 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: